128 related articles for article (PubMed ID: 21544169)
1. Protein-Ligand interaction studies on 2, 4, 6- trisubstituted triazine derivatives as anti-malarial DHFR agents using AutoDock.
Adinarayana KP; Devi RK
Bioinformation; 2011 Mar; 6(2):74-7. PubMed ID: 21544169
[TBL] [Abstract][Full Text] [Related]
2. A comparative molecular docking study of curcumin and methotrexate to dihydrofolate reductase.
Hobani Y; Jerah A; Bidwai A
Bioinformation; 2017; 13(3):63-66. PubMed ID: 28584445
[TBL] [Abstract][Full Text] [Related]
3. Identification of terpenoids as dihydropteroate synthase and dihydrofolate reductase inhibitors through structure-based virtual screening and molecular dynamic simulations.
Saini A; Kumar A; Jangid K; Kumar V; Jaitak V
J Biomol Struct Dyn; 2024; 42(4):1966-1984. PubMed ID: 37173829
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as Potential Antileukemic Agents.
Dolatkhah Z; Javanshir S; Sadr AS; Hosseini J; Sardari S
J Chem Inf Model; 2017 Jun; 57(6):1246-1257. PubMed ID: 28524659
[TBL] [Abstract][Full Text] [Related]
5. Studies on the Interaction between Poly-Phosphane Gold(I) Complexes and Dihydrofolate Reductase: An Interplay with Nicotinamide Adenine Dinucleotide Cofactor.
Pucciarelli S; Vincenzetti S; Ricciutelli M; Simon OC; Ramadori AT; Luciani L; Galassi R
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30979096
[TBL] [Abstract][Full Text] [Related]
6. Novel mechanism-based substrates of dihydrofolate reductase and the thermodynamics of ligand binding: a comparison of theory and experiment for 8-methylpterin and 6,8-dimethylpterin.
Cummins PL; Gready JE
Proteins; 1993 Apr; 15(4):426-35. PubMed ID: 8460112
[TBL] [Abstract][Full Text] [Related]
7. Retraction for Adinarayana & Devi, Protein-Ligand interaction studies on 2, 4, 6-trisubstituted triazine derivatives as anti-malarial DHFR agents using AutoDock.
Bioinformation; 2015; 11(11):515. PubMed ID: 26912954
[TBL] [Abstract][Full Text] [Related]
8. Quassinoids from Eurycoma longifolia as Potential Dihydrofolate Reductase Inhibitors: A Computational Study.
Yunos NM; Al-Thiabat MG; Sallehudin NJ; A Wahab H
Curr Pharm Biotechnol; 2024 Feb; ():. PubMed ID: 38425119
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic analysis of allosteric and non-allosteric effects arising from nanobody binding to two epitopes of the dihydrofolate reductase of Escherichia coli.
Oyen D; Wechselberger R; Srinivasan V; Steyaert J; Barlow JN
Biochim Biophys Acta; 2013 Oct; 1834(10):2147-57. PubMed ID: 23911607
[TBL] [Abstract][Full Text] [Related]
10. Phthalide derivatives as dihydrofolate reductase inhibitors for malaria: molecular docking and molecular dynamics studies.
Ibraheem W; Makki AA; Alzain AA
J Biomol Struct Dyn; 2023 Jul; 41(11):5127-5137. PubMed ID: 35635144
[No Abstract] [Full Text] [Related]
11. Unveiling the Efficacy of Sesquiterpenes from Marine Sponge
Omar AM; Mohammad KA; Sindi IA; Mohamed GA; Ibrahim SRM
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770958
[TBL] [Abstract][Full Text] [Related]
12. Modeling the inhibition of quadruple mutant Plasmodium falciparum dihydrofolate reductase by pyrimethamine derivatives.
Fogel GB; Cheung M; Pittman E; Hecht D
J Comput Aided Mol Des; 2008 Jan; 22(1):29-38. PubMed ID: 18071909
[TBL] [Abstract][Full Text] [Related]
13. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
Kesharwani RK; Singh DV; Misra K
J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
[TBL] [Abstract][Full Text] [Related]
14. Computational analysis of binding between malarial dihydrofolate reductases and anti-folates.
Choowongkomon K; Theppabutr S; Songtawee N; Day NP; White NJ; Woodrow CJ; Imwong M
Malar J; 2010 Mar; 9():65. PubMed ID: 20193090
[TBL] [Abstract][Full Text] [Related]
15. Oplodiol and nitidine as potential inhibitors of
Akakpo L; Gasu EN; Mensah JO; Borquaye LS
J Biomol Struct Dyn; 2024; 42(4):1655-1669. PubMed ID: 37194452
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyenone Derivatives: In vitro Anti-malarial and Docking Studies against P. falciparum.
Dalal A; Kumar P; Khanna R; Kumar D; Paliwal D; Kamboj RC
Infect Disord Drug Targets; 2020; 20(2):237-243. PubMed ID: 30652652
[TBL] [Abstract][Full Text] [Related]
17. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2.
Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A
J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking and QSAR studies for modeling the antimalarial activity of hybrids 4-anilinoquinoline-triazines derivatives with the wild-type and mutant receptor
Hadni H; Elhallaoui M
Heliyon; 2019 Aug; 5(8):e02357. PubMed ID: 31485537
[No Abstract] [Full Text] [Related]
19. The Performance of Several Docking Programs at Reproducing Protein-Macrolide-Like Crystal Structures.
Castro-Alvarez A; Costa AM; Vilarrasa J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28106755
[TBL] [Abstract][Full Text] [Related]
20. Lead discovery of inhibitors of the dihydrofolate reductase domain of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase.
Toyoda T; Brobey RK; Sano G; Horii T; Tomioka N; Itai A
Biochem Biophys Res Commun; 1997 Jun; 235(3):515-9. PubMed ID: 9207187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
